NYSE: SYK · Industrial Applications and Services · 5 alerts · CIK 310764
Share price
$310.72Close, Nov 16
Market cap
$118B
Shares outstanding
380.69MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Stryker Corp filings on SEC EDGAR ↗
Stryker Insider Ronda E. Stryker Sells $179M of Stock
Ronda E. Stryker sold 550,000 shares of Stryker Corp at $323.19 to $327.69 a share (average $325.32) in 6 transactions, worth $179M in total on Nov 6, 2026. Shares held after the trade: 1,701,375 (-0.6%).
Stryker Corporation has increased its board size from 11 to 12 and elected James E. Davis as a new independent director, effective January 1, 2027. Mr. Davis currently serves as the Chairman, CEO, and President of Quest Diagnostics and brings extensive experience from GE Healthcare and McKinsey & Company. He will receive compensation consistent with the company's existing non-employee director pay structure.
Stryker reported net sales of $6,520 million for the third quarter of 2026, a 7.6% increase over the prior year, though net earnings decreased to $753 million due to higher operating expenses and impairment charges. The company reorganized its Orthopaedics segment to form the Ortho Tech business, combining its orthopaedic instruments and Mako portfolios to streamline innovation.
Stryker reported Q3 2026 net sales of $6.5 billion, representing 7.7% organic growth, though management noted performance fell slightly short of internal expectations. The company also announced a $3.0 billion increase to its share repurchase program and updated its full-year 2026 guidance.
Term
Q3 2026
“We delivered 7.7% organic sales growth and double-digit adjusted earnings growth in the quarter. While, in absolute terms, this reflected good overall performance, it did fall short of our expectations. The underlying fundamentals of the business remain strong, and we expect a solid performance in Q4 and good momentum heading into 2027.”